Equity Analyst

Xin Yu, CFA

An equity research analyst with over 5 years of experience in multiple sectors. Previously worked for a global asset manager, covering China equities in multiple markets including A-shares/H-shares/ADRs and multiple sectors including TMT, industrial, consumer, etc. I conduct fundamental research to invest in high quality companies at an attractive valuation.

Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside

China Internet Weekly (2023Feb27): Meituan, JD, Baidu, IQiyi, NetEase, and Sohu

Equity Bottom-Up

<ul>
<li>Meituan’s recent price decline was partly due to the rumors about the social benefit payments.</li>
<li>First, rumors are unverified statements. There was no such meeting at all.</li>
<li>Second, the social benefit payment impact is probably controllable. I think the recent price decline provides a chance of adding on the stock. </li>
</ul>


Meituan’s recent price decline was partly due to the rumors about the social benefit payments.
First, rumors are unverified statements. There was no such meeting at all.
Second, the social benefit payment impact is probably controllable. I think the recent price decline provides a chance of adding on the stock. 


Add Meituan on Rumors of Social Benefit Payments